FAPI-PET for Tumor Detection
ConditionMalignant Neoplasm
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Essen
About this trial
This is a prospective observational trial investigating correlation with histopathology, positive predictive value, detection rate, reproducibility and impact on clinical management of 68-Ga-FAPI PET/CT or PET/MRI in patients receiving this imaging modality for tumor staging or restaging as part of clinical care.
Eligibility criteria
Qualifiers
FAPI-PET scheduled for staging or restaging as part of clinical routine for proven or suspected malignancy
Age ≥ 18 years.
Disqualifiers
Patient cannot give consent for the study
Patient can not lie flat or tolerate FAPI PET imaging
Unwillingness or inability to comply with study and follow-up procedures
Condition of patient which is critical to participate in this study in the discretion of the investigators
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov